Law Commons^™

Ahs Residential, Llc., Order On Motions For Summary Judgment, Kelly L. Ellerbe

Georgia Business Court Opinions

No abstract provided.

Ahs Residential, Llc., Order On Defendants' Motion To Exclude Opinions Of Plaintiff's Expert Witness Ian Ratner And Plaintiff Ahs Residential Llc's Motion To Limit The Testimony, Kelly L. Ellerbe

Georgia Business Court Opinions

No abstract provided.

H.J. Russell & Company, Order Granting With Prejudice Defendants' Join Motion To Dismiss, Wesley B. Tailor

Georgia Business Court Opinions

No abstract provided.

Troy Welker And Min Turner V. Mimedx Group, Inc., Et Al., Order On Motions To Dismiss, John J. Goger

Georgia Business Court Opinions

No abstract provided.

Bernard Parks Jr., And Bpj Enterprises, Inc., Order On Discovery Motions, John J. Goger

Georgia Business Court Opinions

No abstract provided.

2022-2023 Gsulr Masthead, Georgia State University Law Review

Law Review Mastheads

No abstract provided.

Introduction, John T. Marshall, Ryan Rowberry, Susan S. Kuo

Faculty Publications By Year

No abstract provided.

Todd A. Brown And Michael S. Brown As Plaintiffs In Several Consolidated Matters, Consent Order, Wesley B. Tailor

Georgia Business Court Opinions

No abstract provided.

Bernard Bronner, Order On Defendants' And Counterclaim Plaintiffs' Motion To Dismiss, Kelly L. Ellerbe

Georgia Business Court Opinions

No abstract provided.

Galaxy Next Generation, Inc., Order On Counterclaim Defendant Wade Walker's Motion For Protective Order And To Quash Defendant/Counterclaim-Plaintiff Bradley Ehlert's Requests And Subpoena For Production Of Documents To Non-Parties, Kelly L. Ellerbe

Georgia Business Court Opinions

No abstract provided.

Galaxy Next Generation, Inc., Order On Counterclaim Defendant Wade Walker's Motion To Dismiss For Lack Of Personal Jurisdiciton And Venue And Counterclaim Plaintiff Bradley Ehlert's Motion For Permission To File Out Of Time Brief In Opposition To Walker's Motion To Dismiss, Kelly L. Ellerbe

Georgia Business Court Opinions

No abstract provided.

First Inside Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Table Of Contents, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Lying At Plea Bargaining, Thea Johnson

Georgia State University Law Review

This Article describes the regular use of lying during plea bargaining by criminal justice stakeholders and the paradox it presents for those who care about creating a fairer criminal legal system. The paradox is this: lying at plea bargaining allows defendants the opportunity to negotiate fair resolutions to their cases in the face of a deeply unfair system, even as that lying makes way for—and sustains—the problematic system it seeks to avoid.

The Article lays out a taxonomy of lying at plea bargaining by organizing the types of lies into three categories: lies about facts, lies about law, and lies …

Tax Coordination, Blaine G. Saito

Georgia State University Law Review

The United States implements much of its social policy through its income tax laws. The Code is rife with tax expenditures for education, housing, community economic development, retirement savings, and health care to name a few. But the IRS is not an agency with expertise in any of these areas and developing such expertise would draw resources away from its core tax administration mission. Commentators have thus called for a series of changes from turning these tax expenditures into outlays for these programs to divesting the IRS/Treasury of most of the administration of social policy tax expenditures. Yet, given American …

Cost-Effectiveness Comes To America: The Promise And Perils Of Cost-Effective Analysis In Medication Coverage Decisions, Carl Coleman

Georgia State University Law Review

In an effort to control rising drug costs, some health insurers have begun experimenting with methods to link decisions about coverage to the value added by medicines, including through the use of formal cost-effectiveness analysis (CEA). Increased interest in subjecting new drugs to rigorous economic analysis is a welcome development, as it offers the potential to minimize wasteful spending on drugs whose high prices are not justified by evidence of additional benefits produced. At the same time, CEA raises significant ethical issues, particularly when payers use it to limit access to drugs deemed to provide insufficient value for money. For …

Jurisdiction At Work: Specific Personal Jurisdiction In Flsa Collective Actions After Bristol-Myers Squibb, Anaid Reyes Kipp

Georgia State University Law Review

In Bristol-Myers Squibb Co. v. Superior Court (BMS), eighty-six California residents and five hundred ninety-two nonresidents from thirty-three different states, who had originally filed eight separate complaints, used ordinary party joinder rules to file a mass tort action in California state court, alleging that Bristol-Myers Squibb’s blood-thinning drug made them sick. The Supreme Court held in 2017 that the California state court did not have specific personal jurisdiction over the national pharmaceutical company because its contacts with California were insufficient in relation to the claims by nonresident plaintiffs. Although BMS was a mass action filed in state court, its …

404 Provider Not Found: Contributions And Solutions To Inadequate Provider Networks For Behavioral Health Care, Travis Williams

Georgia State University Law Review

Despite the efforts of policymakers, access to in-network behavioral health care services has continued to lag relative to other types of health care. Many psychiatrists, for example, do not accept insurance, limiting access to their services to only those individuals who can afford to pay out of pocket. Several factors contribute to insurance networks’ paucity of behavioral health care providers, including low insurance reimbursement for behavioral health care services, inadequate regulation and enforcement, provider shortages, and a lack of access to telehealth services. To maximize the utility of existing regulatory structures, states should take an outcome-oriented enforcement approach that principally …

Cover Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Inside Front Cover Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Member Masthead, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Spring 2022 Cover Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Inside Front Cover Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Copyright Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Member Masthead, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Faculty Masthead, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

A Regulatory Budget For The Public Company Accounting Oversight Board, J.W. Verret

Georgia State University Law Review

The Public Company Accounting Standards Board (PCAOB) was created by the Sarbanes–Oxley Act (SOX) in 2002 in response to the Enron and WorldCom auditing scandals. The PCAOB regulates the $20 billion annual auditing industry, which itself provides assurance for the financial integrity of $27 trillion in outstanding global publicly traded equity. The PCAOB is uniquely a quasi-private entity overseen by the Securities and Exchange Commission (SEC), which approves its budget and must approve any changes in its rules. The PCAOB has undertaken initiatives to attenuate the cost–benefit calculus of its rules, most notably in a change from Auditing Standard 2 …

Does Size Matter? Nanoscale Particle Size As An Indicator Of Inherency In Nanopharmaceutical Patent Validity, Kirsten Fehlan

Georgia State University Law Review

Scientific and technological advances in nanopharmaceuticals bring the doctrine of inherent obviousness to a head. On the one hand, nanotechnology promises to offer novel ways to target and treat traditionally incurable diseases by operating at a scale that is comparable to the scales that most biological systems use. On the other hand, nanotechnology inventions that result in improved pharmacokinetic properties are susceptible to validity challenges based on inherent obviousness.

Inherency and obviousness are two independently recognized and well-understood principles in United States patent law. Inherency refers to a claimed limitation or feature that is either necessarily present in, or the …

First Inside Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.

Copyright Page, Georgia State University Law Review

Georgia State University Law Review

No abstract provided.